Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Pharmacokinetics
97%
Inflammation
73%
Inflammatory Bowel Disease
35%
Ustekinumab
33%
Crohn's Disease
33%
Esophagus Cancer
33%
Vedolizumab
33%
Gemcitabine
33%
Neutropenia
33%
Indometacin
33%
Coronavirus Infection
33%
Antivirus Agent
14%
Interleukin 23
14%
Coronavirinae
11%
Elimination
10%
Remission
8%
Prospective Study
7%
Therapeutic Drug Monitoring
7%
Interferon
7%
Alpha Interferon
7%
Clinical Trial
6%
Malignant Neoplasm
6%
Calgranulin
5%
Immunology and Microbiology
Tissue Level
42%
Blood Level
39%
Inflammatory Bowel Disease
35%
Viral Replication
33%
Inflammation Response
33%
Ustekinumab
33%
Crohn's Disease
33%
Vedolizumab
33%
Coronavirinae
33%
Skeletal Muscle
33%
Body Composition
33%
Adipose Tissue
16%
Pharmacokinetics
16%
Interleukin 23
14%
Interferon Type I
13%
Coronavirus
13%
Interferon Alfa
13%
Body Surface
13%
Surface Area
13%
Macrophage
6%
COVID-19
6%
Organoid
6%
Human Cell
6%
Coculture
6%
STAT1
6%
Medicine and Dentistry
Treatment Response
33%
Serositis
33%
Indometacin
33%
Virus Replication
33%
Coronavirus Infection
33%
Vedolizumab
33%
Inflammatory Bowel Disease
33%
Antivirus Agent
14%
Coronavirinae
11%
Interferon Alfa
7%
Coronavirus
7%
Interferon
7%